JP2004513171A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004513171A5 JP2004513171A5 JP2002541100A JP2002541100A JP2004513171A5 JP 2004513171 A5 JP2004513171 A5 JP 2004513171A5 JP 2002541100 A JP2002541100 A JP 2002541100A JP 2002541100 A JP2002541100 A JP 2002541100A JP 2004513171 A5 JP2004513171 A5 JP 2004513171A5
- Authority
- JP
- Japan
- Prior art keywords
- trifluoromethylimidazo
- phenyl
- triazine
- fluoro
- triazin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims description 72
- 229910052739 hydrogen Inorganic materials 0.000 claims description 22
- 239000001257 hydrogen Substances 0.000 claims description 22
- 150000003839 salts Chemical class 0.000 claims description 22
- 125000000217 alkyl group Chemical group 0.000 claims description 18
- 239000000651 prodrug Substances 0.000 claims description 16
- 229940002612 prodrug Drugs 0.000 claims description 16
- -1 C 1 -6 -alkoxy Chemical group 0.000 claims description 15
- 150000002431 hydrogen Chemical class 0.000 claims description 12
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 11
- 239000000126 substance Substances 0.000 claims description 10
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 8
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 8
- 229910052731 fluorine Inorganic materials 0.000 claims description 8
- 239000011737 fluorine Substances 0.000 claims description 8
- 229910052736 halogen Chemical group 0.000 claims description 8
- 150000002367 halogens Chemical group 0.000 claims description 8
- 125000001072 heteroaryl group Chemical group 0.000 claims description 5
- 239000004215 Carbon black (E152) Substances 0.000 claims description 4
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 4
- 125000000623 heterocyclic group Chemical group 0.000 claims description 4
- 229930195733 hydrocarbon Natural products 0.000 claims description 4
- 150000002430 hydrocarbons Chemical class 0.000 claims description 4
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims description 4
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 4
- 125000003118 aryl group Chemical group 0.000 claims description 3
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 claims description 2
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical compound C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 claims description 2
- JAVOTZBYCURNSM-UHFFFAOYSA-N 1-[3-[2-fluoro-5-[3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazin-7-yl]phenyl]phenyl]ethanone Chemical compound CC(=O)C1=CC=CC(C=2C(=CC=C(C=2)C=2N3N=CC(=NC3=NC=2)C(F)(F)F)F)=C1 JAVOTZBYCURNSM-UHFFFAOYSA-N 0.000 claims description 2
- SJLQLNPRIHCHDY-UHFFFAOYSA-N 1-[3-[3-[3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazin-7-yl]phenyl]phenyl]ethanone Chemical compound CC(=O)C1=CC=CC(C=2C=C(C=CC=2)C=2N3N=CC(=NC3=NC=2)C(F)(F)F)=C1 SJLQLNPRIHCHDY-UHFFFAOYSA-N 0.000 claims description 2
- FMXZGRYCDIPZFC-UHFFFAOYSA-N 1-[4-[3-[3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazin-7-yl]phenyl]phenyl]ethanone Chemical compound C1=CC(C(=O)C)=CC=C1C1=CC=CC(C=2N3N=CC(=NC3=NC=2)C(F)(F)F)=C1 FMXZGRYCDIPZFC-UHFFFAOYSA-N 0.000 claims description 2
- JEGFGPZYKCBKBU-UHFFFAOYSA-N 2-(2-fluoro-5-imidazo[1,2-b][1,2,4]triazin-7-ylphenyl)benzonitrile Chemical compound FC1=CC=C(C=2N3N=CC=NC3=NC=2)C=C1C1=CC=CC=C1C#N JEGFGPZYKCBKBU-UHFFFAOYSA-N 0.000 claims description 2
- PYMNCEZJPMDEPA-UHFFFAOYSA-N 2-[2-fluoro-3-[3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazin-7-yl]phenyl]benzonitrile Chemical compound FC1=C(C=2N3N=CC(=NC3=NC=2)C(F)(F)F)C=CC=C1C1=CC=CC=C1C#N PYMNCEZJPMDEPA-UHFFFAOYSA-N 0.000 claims description 2
- VDUAIIDPYNJYMB-UHFFFAOYSA-N 2-[2-fluoro-5-[3-(2-hydroxypropan-2-yl)imidazo[1,2-b][1,2,4]triazin-7-yl]phenyl]benzonitrile Chemical compound C=1N=C2N=C(C(C)(O)C)C=NN2C=1C(C=1)=CC=C(F)C=1C1=CC=CC=C1C#N VDUAIIDPYNJYMB-UHFFFAOYSA-N 0.000 claims description 2
- VBXZLYYHFDVNEN-UHFFFAOYSA-N 2-[2-fluoro-5-[3-(2-hydroxypropan-2-yl)imidazo[1,2-b][1,2,4]triazin-7-yl]phenyl]pyridine-3-carbonitrile Chemical compound C=1N=C2N=C(C(C)(O)C)C=NN2C=1C(C=1)=CC=C(F)C=1C1=NC=CC=C1C#N VBXZLYYHFDVNEN-UHFFFAOYSA-N 0.000 claims description 2
- YQXPOJCRAKGRMA-UHFFFAOYSA-N 2-[2-fluoro-5-[3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazin-7-yl]phenyl]-1,3-oxazole Chemical compound FC1=CC=C(C=2N3N=CC(=NC3=NC=2)C(F)(F)F)C=C1C1=NC=CO1 YQXPOJCRAKGRMA-UHFFFAOYSA-N 0.000 claims description 2
- FNQVSSGSIGHASS-UHFFFAOYSA-N 2-[2-fluoro-5-[3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazin-7-yl]phenyl]-1,3-thiazole Chemical compound FC1=CC=C(C=2N3N=CC(=NC3=NC=2)C(F)(F)F)C=C1C1=NC=CS1 FNQVSSGSIGHASS-UHFFFAOYSA-N 0.000 claims description 2
- XAKLFBPRRVVCLE-UHFFFAOYSA-N 2-[2-fluoro-5-[3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazin-7-yl]phenyl]-5-nitro-1,3-thiazole Chemical compound S1C([N+](=O)[O-])=CN=C1C1=CC(C=2N3N=CC(=NC3=NC=2)C(F)(F)F)=CC=C1F XAKLFBPRRVVCLE-UHFFFAOYSA-N 0.000 claims description 2
- HBLJPARREFIRGR-UHFFFAOYSA-N 2-[2-fluoro-5-[3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazin-7-yl]phenyl]-n,n-dimethyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)N(C)C)=CN=C1C1=CC(C=2N3N=CC(=NC3=NC=2)C(F)(F)F)=CC=C1F HBLJPARREFIRGR-UHFFFAOYSA-N 0.000 claims description 2
- HCKOUSVQWKTONU-UHFFFAOYSA-N 2-[2-fluoro-5-[3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazin-7-yl]phenyl]benzonitrile Chemical compound FC1=CC=C(C=2N3N=CC(=NC3=NC=2)C(F)(F)F)C=C1C1=CC=CC=C1C#N HCKOUSVQWKTONU-UHFFFAOYSA-N 0.000 claims description 2
- IYZAJLUGZRMKRF-UHFFFAOYSA-N 2-[3-(2-methylimidazo[1,2-b][1,2,4]triazin-7-yl)phenyl]benzonitrile Chemical compound N12N=C(C)C=NC2=NC=C1C(C=1)=CC=CC=1C1=CC=CC=C1C#N IYZAJLUGZRMKRF-UHFFFAOYSA-N 0.000 claims description 2
- BNQJKHFCSDKTCD-UHFFFAOYSA-N 2-[3-(3-methylimidazo[1,2-b][1,2,4]triazin-7-yl)phenyl]benzonitrile Chemical compound C=1N=C2N=C(C)C=NN2C=1C(C=1)=CC=CC=1C1=CC=CC=C1C#N BNQJKHFCSDKTCD-UHFFFAOYSA-N 0.000 claims description 2
- LKODPGNJHMBDDK-UHFFFAOYSA-N 2-[3-[3-(2-hydroxypropan-2-yl)imidazo[1,2-b][1,2,4]triazin-7-yl]phenyl]benzonitrile Chemical compound C=1N=C2N=C(C(C)(O)C)C=NN2C=1C(C=1)=CC=CC=1C1=CC=CC=C1C#N LKODPGNJHMBDDK-UHFFFAOYSA-N 0.000 claims description 2
- QBVJKQBZLPVJDV-UHFFFAOYSA-N 2-[3-[3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazin-7-yl]phenyl]-1,3-thiazole Chemical compound C=1N=C2N=C(C(F)(F)F)C=NN2C=1C(C=1)=CC=CC=1C1=NC=CS1 QBVJKQBZLPVJDV-UHFFFAOYSA-N 0.000 claims description 2
- LQJOSYXKEYEUAG-UHFFFAOYSA-N 2-[3-[3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazin-7-yl]phenyl]benzaldehyde Chemical compound C=1N=C2N=C(C(F)(F)F)C=NN2C=1C(C=1)=CC=CC=1C1=CC=CC=C1C=O LQJOSYXKEYEUAG-UHFFFAOYSA-N 0.000 claims description 2
- WCXZBXSJLJZSSH-UHFFFAOYSA-N 2-[7-(2-fluoro-3-pyridin-4-ylphenyl)imidazo[1,2-b][1,2,4]triazin-3-yl]propan-2-ol Chemical compound C=1N=C2N=C(C(C)(O)C)C=NN2C=1C(C=1F)=CC=CC=1C1=CC=NC=C1 WCXZBXSJLJZSSH-UHFFFAOYSA-N 0.000 claims description 2
- CVPFASNYTKLDJC-UHFFFAOYSA-N 2-[7-(4-fluoro-3-pyridazin-3-ylphenyl)imidazo[1,2-b][1,2,4]triazin-3-yl]propan-2-ol Chemical compound C=1N=C2N=C(C(C)(O)C)C=NN2C=1C(C=1)=CC=C(F)C=1C1=CC=CN=N1 CVPFASNYTKLDJC-UHFFFAOYSA-N 0.000 claims description 2
- XXCGNJISZTZOJB-UHFFFAOYSA-N 2-[7-(4-fluoro-3-pyridazin-4-ylphenyl)imidazo[1,2-b][1,2,4]triazin-3-yl]propan-2-ol Chemical compound C=1N=C2N=C(C(C)(O)C)C=NN2C=1C(C=1)=CC=C(F)C=1C1=CC=NN=C1 XXCGNJISZTZOJB-UHFFFAOYSA-N 0.000 claims description 2
- DZQUECBNJGMGAE-UHFFFAOYSA-N 2-[7-(4-fluoro-3-pyridin-2-ylphenyl)imidazo[1,2-b][1,2,4]triazin-3-yl]propan-2-ol Chemical compound C=1N=C2N=C(C(C)(O)C)C=NN2C=1C(C=1)=CC=C(F)C=1C1=CC=CC=N1 DZQUECBNJGMGAE-UHFFFAOYSA-N 0.000 claims description 2
- LLHQBHOWDZNCNK-UHFFFAOYSA-N 2-[7-(4-fluoro-3-pyridin-3-ylphenyl)imidazo[1,2-b][1,2,4]triazin-3-yl]propan-2-ol Chemical compound C=1N=C2N=C(C(C)(O)C)C=NN2C=1C(C=1)=CC=C(F)C=1C1=CC=CN=C1 LLHQBHOWDZNCNK-UHFFFAOYSA-N 0.000 claims description 2
- BPTASZCHRIMWEF-UHFFFAOYSA-N 2-[7-(4-fluoro-3-pyridin-4-ylphenyl)imidazo[1,2-b][1,2,4]triazin-3-yl]propan-2-ol Chemical compound C=1N=C2N=C(C(C)(O)C)C=NN2C=1C(C=1)=CC=C(F)C=1C1=CC=NC=C1 BPTASZCHRIMWEF-UHFFFAOYSA-N 0.000 claims description 2
- YSCQXQSSTHEHJZ-UHFFFAOYSA-N 2-[7-(4-fluoro-3-pyrimidin-4-ylphenyl)imidazo[1,2-b][1,2,4]triazin-3-yl]propan-2-ol Chemical compound C=1N=C2N=C(C(C)(O)C)C=NN2C=1C(C=1)=CC=C(F)C=1C1=CC=NC=N1 YSCQXQSSTHEHJZ-UHFFFAOYSA-N 0.000 claims description 2
- JFYJHRVIQOEMFA-UHFFFAOYSA-N 2-[7-[3-(3,5-difluoropyridin-2-yl)phenyl]imidazo[1,2-b][1,2,4]triazin-3-yl]propan-2-ol Chemical compound C=1N=C2N=C(C(C)(O)C)C=NN2C=1C(C=1)=CC=CC=1C1=NC=C(F)C=C1F JFYJHRVIQOEMFA-UHFFFAOYSA-N 0.000 claims description 2
- WIACWFSVQJVNGF-UHFFFAOYSA-N 2-[7-[4-fluoro-3-(3-fluoropyridin-2-yl)phenyl]imidazo[1,2-b][1,2,4]triazin-3-yl]propan-2-ol Chemical compound C=1N=C2N=C(C(C)(O)C)C=NN2C=1C(C=1)=CC=C(F)C=1C1=NC=CC=C1F WIACWFSVQJVNGF-UHFFFAOYSA-N 0.000 claims description 2
- QSEBFHRZNPGODU-UHFFFAOYSA-N 2-[7-[4-fluoro-3-(5-fluoropyridin-2-yl)phenyl]imidazo[1,2-b][1,2,4]triazin-3-yl]propan-2-ol Chemical compound C=1N=C2N=C(C(C)(O)C)C=NN2C=1C(C=1)=CC=C(F)C=1C1=CC=C(F)C=N1 QSEBFHRZNPGODU-UHFFFAOYSA-N 0.000 claims description 2
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 claims description 2
- ZYODOZATSVMRJQ-UHFFFAOYSA-N 3,5-difluoro-2-[2-fluoro-5-[3-(2-fluoropropan-2-yl)imidazo[1,2-b][1,2,4]triazin-7-yl]phenyl]benzonitrile Chemical compound C=1N=C2N=C(C(C)(F)C)C=NN2C=1C(C=1)=CC=C(F)C=1C1=C(F)C=C(F)C=C1C#N ZYODOZATSVMRJQ-UHFFFAOYSA-N 0.000 claims description 2
- HUPIGXXHGJDXHG-UHFFFAOYSA-N 3-(1,1-difluoroethyl)-7-(4-fluoro-3-pyridin-3-ylphenyl)imidazo[1,2-b][1,2,4]triazine Chemical compound C=1N=C2N=C(C(F)(F)C)C=NN2C=1C(C=1)=CC=C(F)C=1C1=CC=CN=C1 HUPIGXXHGJDXHG-UHFFFAOYSA-N 0.000 claims description 2
- YYIDJVSSJATAQW-UHFFFAOYSA-N 3-(2-fluoropropan-2-yl)-7-(4-fluoro-3-pyridin-3-ylphenyl)imidazo[1,2-b][1,2,4]triazine Chemical compound C=1N=C2N=C(C(C)(F)C)C=NN2C=1C(C=1)=CC=C(F)C=1C1=CC=CN=C1 YYIDJVSSJATAQW-UHFFFAOYSA-N 0.000 claims description 2
- PNRQFASVYBOWJQ-UHFFFAOYSA-N 3-[2-fluoro-5-[3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazin-7-yl]phenyl]aniline Chemical compound NC1=CC=CC(C=2C(=CC=C(C=2)C=2N3N=CC(=NC3=NC=2)C(F)(F)F)F)=C1 PNRQFASVYBOWJQ-UHFFFAOYSA-N 0.000 claims description 2
- BWFZJAHQMPIHMS-UHFFFAOYSA-N 3-[3-[2-fluoro-5-[3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazin-7-yl]phenyl]phenyl]prop-2-enoic acid Chemical compound OC(=O)C=CC1=CC=CC(C=2C(=CC=C(C=2)C=2N3N=CC(=NC3=NC=2)C(F)(F)F)F)=C1 BWFZJAHQMPIHMS-UHFFFAOYSA-N 0.000 claims description 2
- LFWROMCSALLJEF-UHFFFAOYSA-N 3-[3-[3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazin-7-yl]phenyl]thiophene-2-carbaldehyde Chemical compound C=1N=C2N=C(C(F)(F)F)C=NN2C=1C(C=1)=CC=CC=1C=1C=CSC=1C=O LFWROMCSALLJEF-UHFFFAOYSA-N 0.000 claims description 2
- SMXUZEFGNVLKGG-UHFFFAOYSA-N 3-fluoro-2-[2-fluoro-5-[3-(2-fluoropropan-2-yl)imidazo[1,2-b][1,2,4]triazin-7-yl]phenyl]benzonitrile Chemical compound C=1N=C2N=C(C(C)(F)C)C=NN2C=1C(C=1)=CC=C(F)C=1C1=C(F)C=CC=C1C#N SMXUZEFGNVLKGG-UHFFFAOYSA-N 0.000 claims description 2
- PWGQRWCRGIHOKN-UHFFFAOYSA-N 3-methyl-5-[3-[3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazin-7-yl]phenyl]-1,2,4-oxadiazole Chemical compound CC1=NOC(C=2C=C(C=CC=2)C=2N3N=CC(=NC3=NC=2)C(F)(F)F)=N1 PWGQRWCRGIHOKN-UHFFFAOYSA-N 0.000 claims description 2
- YIPZYLYYEIVKEQ-UHFFFAOYSA-N 3-tert-butyl-7-(4-fluoro-3-pyridin-2-ylphenyl)imidazo[1,2-b][1,2,4]triazine Chemical compound C=1N=C2N=C(C(C)(C)C)C=NN2C=1C(C=1)=CC=C(F)C=1C1=CC=CC=N1 YIPZYLYYEIVKEQ-UHFFFAOYSA-N 0.000 claims description 2
- FMUXIJDACFSDHS-UHFFFAOYSA-N 3-tert-butyl-7-(4-fluoro-3-pyridin-3-ylphenyl)imidazo[1,2-b][1,2,4]triazine Chemical compound C=1N=C2N=C(C(C)(C)C)C=NN2C=1C(C=1)=CC=C(F)C=1C1=CC=CN=C1 FMUXIJDACFSDHS-UHFFFAOYSA-N 0.000 claims description 2
- YLDRVNNGBACDSD-UHFFFAOYSA-N 4-[2-fluoro-5-[3-(2-hydroxypropan-2-yl)imidazo[1,2-b][1,2,4]triazin-7-yl]phenyl]pyridine-3-carbonitrile Chemical compound C=1N=C2N=C(C(C)(O)C)C=NN2C=1C(C=1)=CC=C(F)C=1C1=CC=NC=C1C#N YLDRVNNGBACDSD-UHFFFAOYSA-N 0.000 claims description 2
- VSZZYAJBIGSJJF-UHFFFAOYSA-N 4-[2-fluoro-5-[3-(2-hydroxypropan-2-yl)imidazo[1,2-b][1,2,4]triazin-7-yl]phenyl]pyrimidine-5-carbonitrile Chemical compound C=1N=C2N=C(C(C)(O)C)C=NN2C=1C(C=1)=CC=C(F)C=1C1=NC=NC=C1C#N VSZZYAJBIGSJJF-UHFFFAOYSA-N 0.000 claims description 2
- CSCIMRWVMYPARG-UHFFFAOYSA-N 4-[2-fluoro-5-[3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazin-7-yl]phenyl]-1,3-thiazole Chemical compound FC1=CC=C(C=2N3N=CC(=NC3=NC=2)C(F)(F)F)C=C1C1=CSC=N1 CSCIMRWVMYPARG-UHFFFAOYSA-N 0.000 claims description 2
- BWKUJRRTHFXVQJ-UHFFFAOYSA-N 4-[2-fluoro-5-[3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazin-7-yl]phenyl]benzaldehyde Chemical compound FC1=CC=C(C=2N3N=CC(=NC3=NC=2)C(F)(F)F)C=C1C1=CC=C(C=O)C=C1 BWKUJRRTHFXVQJ-UHFFFAOYSA-N 0.000 claims description 2
- CGLOVIUBADXELF-UHFFFAOYSA-N 4-[2-fluoro-5-[3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazin-7-yl]phenyl]phenol Chemical compound C1=CC(O)=CC=C1C1=CC(C=2N3N=CC(=NC3=NC=2)C(F)(F)F)=CC=C1F CGLOVIUBADXELF-UHFFFAOYSA-N 0.000 claims description 2
- UKMPTAZPLVNBGN-UHFFFAOYSA-N 4-[3-[3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazin-7-yl]phenyl]-1,3-thiazole Chemical compound C=1N=C2N=C(C(F)(F)F)C=NN2C=1C(C=1)=CC=CC=1C1=CSC=N1 UKMPTAZPLVNBGN-UHFFFAOYSA-N 0.000 claims description 2
- BJHWIIMZXLYGMX-UHFFFAOYSA-N 4-[3-[3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazin-7-yl]phenyl]benzaldehyde Chemical compound C=1N=C2N=C(C(F)(F)F)C=NN2C=1C(C=1)=CC=CC=1C1=CC=C(C=O)C=C1 BJHWIIMZXLYGMX-UHFFFAOYSA-N 0.000 claims description 2
- CKGQTLXSYOGMAD-UHFFFAOYSA-N 4-[3-[3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazin-7-yl]phenyl]benzonitrile Chemical compound C=1N=C2N=C(C(F)(F)F)C=NN2C=1C(C=1)=CC=CC=1C1=CC=C(C#N)C=C1 CKGQTLXSYOGMAD-UHFFFAOYSA-N 0.000 claims description 2
- DQYAZOUZZJBDOL-UHFFFAOYSA-N 4-[3-[3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazin-7-yl]phenyl]thiadiazole Chemical compound C=1N=C2N=C(C(F)(F)F)C=NN2C=1C(C=1)=CC=CC=1C1=CSN=N1 DQYAZOUZZJBDOL-UHFFFAOYSA-N 0.000 claims description 2
- FNSOTIBCHRCQOM-UHFFFAOYSA-N 5-methyl-2-[3-[3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazin-7-yl]phenyl]-3h-1,2,4-oxadiazole Chemical compound O1C(C)=NCN1C1=CC=CC(C=2N3N=CC(=NC3=NC=2)C(F)(F)F)=C1 FNSOTIBCHRCQOM-UHFFFAOYSA-N 0.000 claims description 2
- GGGJYPFNMSJOHP-UHFFFAOYSA-N 5-methyl-2-[3-[3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazin-7-yl]phenyl]-3h-1,2,4-thiadiazole Chemical compound S1C(C)=NCN1C1=CC=CC(C=2N3N=CC(=NC3=NC=2)C(F)(F)F)=C1 GGGJYPFNMSJOHP-UHFFFAOYSA-N 0.000 claims description 2
- MHDMKOLJRLORCW-UHFFFAOYSA-N 7-(2-fluoro-3-pyridin-4-ylphenyl)-3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazine Chemical compound FC1=C(C=2N3N=CC(=NC3=NC=2)C(F)(F)F)C=CC=C1C1=CC=NC=C1 MHDMKOLJRLORCW-UHFFFAOYSA-N 0.000 claims description 2
- KHANQYYVUWTKCX-UHFFFAOYSA-N 7-(3-imidazol-1-ylphenyl)-3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazine Chemical compound C=1N=C2N=C(C(F)(F)F)C=NN2C=1C(C=1)=CC=CC=1N1C=CN=C1 KHANQYYVUWTKCX-UHFFFAOYSA-N 0.000 claims description 2
- BONFPQLOXKVPIA-UHFFFAOYSA-N 7-(3-pyrazin-2-ylphenyl)-3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazine Chemical compound C=1N=C2N=C(C(F)(F)F)C=NN2C=1C(C=1)=CC=CC=1C1=CN=CC=N1 BONFPQLOXKVPIA-UHFFFAOYSA-N 0.000 claims description 2
- NYNXZPNTZUUTII-UHFFFAOYSA-N 7-(3-pyridin-2-ylphenyl)-3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazine Chemical compound C=1N=C2N=C(C(F)(F)F)C=NN2C=1C(C=1)=CC=CC=1C1=CC=CC=N1 NYNXZPNTZUUTII-UHFFFAOYSA-N 0.000 claims description 2
- HHSYSDDEPRWLSN-UHFFFAOYSA-N 7-(3-pyridin-3-ylphenyl)-3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazine Chemical compound C=1N=C2N=C(C(F)(F)F)C=NN2C=1C(C=1)=CC=CC=1C1=CC=CN=C1 HHSYSDDEPRWLSN-UHFFFAOYSA-N 0.000 claims description 2
- MXHKCAVBILRRFE-UHFFFAOYSA-N 7-(3-pyridin-4-ylphenyl)-3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazine Chemical compound C=1N=C2N=C(C(F)(F)F)C=NN2C=1C(C=1)=CC=CC=1C1=CC=NC=C1 MXHKCAVBILRRFE-UHFFFAOYSA-N 0.000 claims description 2
- KEGCQENQLINORT-UHFFFAOYSA-N 7-(3-pyrrol-1-ylphenyl)-3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazine Chemical compound C=1N=C2N=C(C(F)(F)F)C=NN2C=1C(C=1)=CC=CC=1N1C=CC=C1 KEGCQENQLINORT-UHFFFAOYSA-N 0.000 claims description 2
- CAMGAXYEZCKUEL-UHFFFAOYSA-N 7-(3-thiophen-2-ylphenyl)-3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazine Chemical compound C=1N=C2N=C(C(F)(F)F)C=NN2C=1C(C=1)=CC=CC=1C1=CC=CS1 CAMGAXYEZCKUEL-UHFFFAOYSA-N 0.000 claims description 2
- KPPJEGSZVMTVRB-UHFFFAOYSA-N 7-(3-thiophen-3-ylphenyl)-3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazine Chemical compound C=1N=C2N=C(C(F)(F)F)C=NN2C=1C(C=1)=CC=CC=1C=1C=CSC=1 KPPJEGSZVMTVRB-UHFFFAOYSA-N 0.000 claims description 2
- ONEYJCPOQUKAIR-UHFFFAOYSA-N 7-(4-chloro-3-pyridin-3-ylphenyl)-3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazine Chemical compound C=1N=C2N=C(C(F)(F)F)C=NN2C=1C(C=1)=CC=C(Cl)C=1C1=CC=CN=C1 ONEYJCPOQUKAIR-UHFFFAOYSA-N 0.000 claims description 2
- LSXPZNREAAPJKF-UHFFFAOYSA-N 7-(4-fluoro-3-imidazol-1-ylphenyl)-3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazine Chemical compound FC1=CC=C(C=2N3N=CC(=NC3=NC=2)C(F)(F)F)C=C1N1C=CN=C1 LSXPZNREAAPJKF-UHFFFAOYSA-N 0.000 claims description 2
- YNUCMMQAYPZJBU-UHFFFAOYSA-N 7-(4-fluoro-3-pyrazol-1-ylphenyl)-3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazine Chemical compound FC1=CC=C(C=2N3N=CC(=NC3=NC=2)C(F)(F)F)C=C1N1C=CC=N1 YNUCMMQAYPZJBU-UHFFFAOYSA-N 0.000 claims description 2
- LPJNVDXBKUPNFK-UHFFFAOYSA-N 7-(4-fluoro-3-pyridin-2-ylphenyl)-3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazine Chemical compound FC1=CC=C(C=2N3N=CC(=NC3=NC=2)C(F)(F)F)C=C1C1=CC=CC=N1 LPJNVDXBKUPNFK-UHFFFAOYSA-N 0.000 claims description 2
- WDOHOIKMRMPGRB-UHFFFAOYSA-N 7-(4-fluoro-3-pyridin-3-ylphenyl)-3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazine Chemical compound FC1=CC=C(C=2N3N=CC(=NC3=NC=2)C(F)(F)F)C=C1C1=CC=CN=C1 WDOHOIKMRMPGRB-UHFFFAOYSA-N 0.000 claims description 2
- ZZCDKXJZGLAQMN-UHFFFAOYSA-N 7-[3-(1,2,4-triazol-1-yl)phenyl]-3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazine Chemical compound C=1N=C2N=C(C(F)(F)F)C=NN2C=1C(C=1)=CC=CC=1N1C=NC=N1 ZZCDKXJZGLAQMN-UHFFFAOYSA-N 0.000 claims description 2
- FYNZTDAJDIAOBJ-UHFFFAOYSA-N 7-[3-(1-ethylpyrazol-3-yl)phenyl]-3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazine Chemical compound CCN1C=CC(C=2C=C(C=CC=2)C=2N3N=CC(=NC3=NC=2)C(F)(F)F)=N1 FYNZTDAJDIAOBJ-UHFFFAOYSA-N 0.000 claims description 2
- UUZPXUGZZUUMCF-UHFFFAOYSA-N 7-[3-(1-methyl-1,2,4-triazol-3-yl)phenyl]-3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazine Chemical compound CN1C=NC(C=2C=C(C=CC=2)C=2N3N=CC(=NC3=NC=2)C(F)(F)F)=N1 UUZPXUGZZUUMCF-UHFFFAOYSA-N 0.000 claims description 2
- YZKQQDDYAPFXKL-UHFFFAOYSA-N 7-[3-(1-methylpyrazol-3-yl)phenyl]-3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazine Chemical compound CN1C=CC(C=2C=C(C=CC=2)C=2N3N=CC(=NC3=NC=2)C(F)(F)F)=N1 YZKQQDDYAPFXKL-UHFFFAOYSA-N 0.000 claims description 2
- DMBVOOINJRHNLD-UHFFFAOYSA-N 7-[3-(2-methoxyphenyl)phenyl]-3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazine Chemical compound COC1=CC=CC=C1C1=CC=CC(C=2N3N=CC(=NC3=NC=2)C(F)(F)F)=C1 DMBVOOINJRHNLD-UHFFFAOYSA-N 0.000 claims description 2
- KCSSZQYRTOUTCH-UHFFFAOYSA-N 7-[3-(2-methyltetrazol-5-yl)phenyl]-3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazine Chemical compound CN1N=NC(C=2C=C(C=CC=2)C=2N3N=CC(=NC3=NC=2)C(F)(F)F)=N1 KCSSZQYRTOUTCH-UHFFFAOYSA-N 0.000 claims description 2
- DZJITHDTCFWHSD-UHFFFAOYSA-N 7-[3-(2-methyltriazol-4-yl)phenyl]-3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazine Chemical compound CN1N=CC(C=2C=C(C=CC=2)C=2N3N=CC(=NC3=NC=2)C(F)(F)F)=N1 DZJITHDTCFWHSD-UHFFFAOYSA-N 0.000 claims description 2
- LQWDTLCEHXOMAL-UHFFFAOYSA-N 7-[3-(3,4-dimethoxyphenyl)-4-fluorophenyl]-3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazine Chemical compound C1=C(OC)C(OC)=CC=C1C1=CC(C=2N3N=CC(=NC3=NC=2)C(F)(F)F)=CC=C1F LQWDTLCEHXOMAL-UHFFFAOYSA-N 0.000 claims description 2
- UJNMXTRHIFJXRY-UHFFFAOYSA-N 7-[3-(3,5-difluoropyridin-2-yl)-4-fluorophenyl]-3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazine Chemical compound FC1=CC(F)=CN=C1C1=CC(C=2N3N=CC(=NC3=NC=2)C(F)(F)F)=CC=C1F UJNMXTRHIFJXRY-UHFFFAOYSA-N 0.000 claims description 2
- JRLZVTMBPVCSGQ-UHFFFAOYSA-N 7-[3-(3-nitrophenyl)phenyl]-3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazine Chemical compound [O-][N+](=O)C1=CC=CC(C=2C=C(C=CC=2)C=2N3N=CC(=NC3=NC=2)C(F)(F)F)=C1 JRLZVTMBPVCSGQ-UHFFFAOYSA-N 0.000 claims description 2
- VODSAYQEQFPKJA-UHFFFAOYSA-N 7-[3-(4-fluoropyridin-2-yl)phenyl]-3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazine Chemical compound FC1=CC=NC(C=2C=C(C=CC=2)C=2N3N=CC(=NC3=NC=2)C(F)(F)F)=C1 VODSAYQEQFPKJA-UHFFFAOYSA-N 0.000 claims description 2
- WYSSXCWGFXLFKU-UHFFFAOYSA-N 7-[3-(4-methylpyridin-2-yl)phenyl]-3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazine Chemical compound CC1=CC=NC(C=2C=C(C=CC=2)C=2N3N=CC(=NC3=NC=2)C(F)(F)F)=C1 WYSSXCWGFXLFKU-UHFFFAOYSA-N 0.000 claims description 2
- BRXQXPYJZTUBPG-UHFFFAOYSA-N 7-[3-(5-fluoropyridin-2-yl)phenyl]-3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazine Chemical compound N1=CC(F)=CC=C1C1=CC=CC(C=2N3N=CC(=NC3=NC=2)C(F)(F)F)=C1 BRXQXPYJZTUBPG-UHFFFAOYSA-N 0.000 claims description 2
- JKDMQLNJUOITRZ-UHFFFAOYSA-N 7-[3-(6-methoxypyridazin-4-yl)phenyl]-3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazine Chemical compound N1=NC(OC)=CC(C=2C=C(C=CC=2)C=2N3N=CC(=NC3=NC=2)C(F)(F)F)=C1 JKDMQLNJUOITRZ-UHFFFAOYSA-N 0.000 claims description 2
- KWZIJLQUJGIGJH-UHFFFAOYSA-N 7-[4-fluoro-3-(1,2,4-triazol-1-yl)phenyl]-3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazine Chemical compound FC1=CC=C(C=2N3N=CC(=NC3=NC=2)C(F)(F)F)C=C1N1C=NC=N1 KWZIJLQUJGIGJH-UHFFFAOYSA-N 0.000 claims description 2
- DIHGZZHFINLASN-UHFFFAOYSA-N 7-[4-fluoro-3-(1-methylpyrazol-4-yl)phenyl]-3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazine Chemical compound C1=NN(C)C=C1C1=CC(C=2N3N=CC(=NC3=NC=2)C(F)(F)F)=CC=C1F DIHGZZHFINLASN-UHFFFAOYSA-N 0.000 claims description 2
- PXQHDLWGOAISIM-UHFFFAOYSA-N 7-[4-fluoro-3-(2-methoxyphenyl)phenyl]-3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazine Chemical compound COC1=CC=CC=C1C1=CC(C=2N3N=CC(=NC3=NC=2)C(F)(F)F)=CC=C1F PXQHDLWGOAISIM-UHFFFAOYSA-N 0.000 claims description 2
- RMBZRSWXPSLETL-UHFFFAOYSA-N 7-[4-fluoro-3-(2-methylsulfonylphenyl)phenyl]-3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazine Chemical compound CS(=O)(=O)C1=CC=CC=C1C1=CC(C=2N3N=CC(=NC3=NC=2)C(F)(F)F)=CC=C1F RMBZRSWXPSLETL-UHFFFAOYSA-N 0.000 claims description 2
- ZQVZEAQJXXDHIY-UHFFFAOYSA-N 7-[4-fluoro-3-(2-methyltetrazol-5-yl)phenyl]-3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazine Chemical compound CN1N=NC(C=2C(=CC=C(C=2)C=2N3N=CC(=NC3=NC=2)C(F)(F)F)F)=N1 ZQVZEAQJXXDHIY-UHFFFAOYSA-N 0.000 claims description 2
- VYNWMAODWXAKMQ-UHFFFAOYSA-N 7-[4-fluoro-3-(4-fluorophenyl)phenyl]-3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazine Chemical compound C1=CC(F)=CC=C1C1=CC(C=2N3N=CC(=NC3=NC=2)C(F)(F)F)=CC=C1F VYNWMAODWXAKMQ-UHFFFAOYSA-N 0.000 claims description 2
- LVIZGUWETGQRJR-UHFFFAOYSA-N 7-[4-fluoro-3-(4-fluoropyridin-3-yl)phenyl]-3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazine Chemical compound FC1=CC=NC=C1C1=CC(C=2N3N=CC(=NC3=NC=2)C(F)(F)F)=CC=C1F LVIZGUWETGQRJR-UHFFFAOYSA-N 0.000 claims description 2
- VUPNXVABOXDOJC-UHFFFAOYSA-N 7-[4-fluoro-3-(4-methoxyphenyl)phenyl]-3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazine Chemical compound C1=CC(OC)=CC=C1C1=CC(C=2N3N=CC(=NC3=NC=2)C(F)(F)F)=CC=C1F VUPNXVABOXDOJC-UHFFFAOYSA-N 0.000 claims description 2
- AFHKBGYETHVEEX-UHFFFAOYSA-N 7-[4-fluoro-3-(4-methylsulfanylphenyl)phenyl]-3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazine Chemical compound C1=CC(SC)=CC=C1C1=CC(C=2N3N=CC(=NC3=NC=2)C(F)(F)F)=CC=C1F AFHKBGYETHVEEX-UHFFFAOYSA-N 0.000 claims description 2
- GZMDZIBAQQBRAC-UHFFFAOYSA-N 7-[4-fluoro-3-(5-fluoropyridin-2-yl)phenyl]-3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazine Chemical compound N1=CC(F)=CC=C1C1=CC(C=2N3N=CC(=NC3=NC=2)C(F)(F)F)=CC=C1F GZMDZIBAQQBRAC-UHFFFAOYSA-N 0.000 claims description 2
- KHUKUFKSRRGWCP-UHFFFAOYSA-N [4-[3-[3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazin-7-yl]phenyl]phenyl]methanol Chemical compound C1=CC(CO)=CC=C1C1=CC=CC(C=2N3N=CC(=NC3=NC=2)C(F)(F)F)=C1 KHUKUFKSRRGWCP-UHFFFAOYSA-N 0.000 claims description 2
- 230000002411 adverse Effects 0.000 claims description 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 2
- 125000004448 alkyl carbonyl group Chemical group 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims description 2
- 239000003937 drug carrier Substances 0.000 claims description 2
- 125000001153 fluoro group Chemical group F* 0.000 claims description 2
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims description 2
- 125000005843 halogen group Chemical group 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- MQGVSNJQXHZFOG-UHFFFAOYSA-N n-[3-[3-[3-(trifluoromethyl)imidazo[1,2-b][1,2,4]triazin-7-yl]phenyl]phenyl]acetamide Chemical compound CC(=O)NC1=CC=CC(C=2C=C(C=CC=2)C=2N3N=CC(=NC3=NC=2)C(F)(F)F)=C1 MQGVSNJQXHZFOG-UHFFFAOYSA-N 0.000 claims description 2
- 230000000926 neurological effect Effects 0.000 claims description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 2
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims description 2
- 238000011282 treatment Methods 0.000 claims description 2
- PCZLQMGFNUNVOM-UHFFFAOYSA-N 3-fluoro-2-[2-fluoro-5-[3-(2-hydroxypropan-2-yl)imidazo[1,2-b][1,2,4]triazin-7-yl]phenyl]benzonitrile Chemical compound C=1N=C2N=C(C(C)(O)C)C=NN2C=1C(C=1)=CC=C(F)C=1C1=C(F)C=CC=C1C#N PCZLQMGFNUNVOM-UHFFFAOYSA-N 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 239000003054 catalyst Substances 0.000 description 2
- 229910052723 transition metal Inorganic materials 0.000 description 2
- 150000003624 transition metals Chemical class 0.000 description 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 1
- GFISDBXSWQMOND-UHFFFAOYSA-N 2,5-dimethoxyoxolane Chemical compound COC1CCC(OC)O1 GFISDBXSWQMOND-UHFFFAOYSA-N 0.000 description 1
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 1
- 125000005620 boronic acid group Chemical group 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0027562A GB0027562D0 (en) | 2000-11-10 | 2000-11-10 | Therapeutic agents |
| GBGB0117277.4A GB0117277D0 (en) | 2001-07-16 | 2001-07-16 | Therapeutic agents |
| PCT/GB2001/004948 WO2002038568A1 (en) | 2000-11-10 | 2001-11-08 | Imidazo-triazine derivatives as ligands for gaba receptors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004513171A JP2004513171A (ja) | 2004-04-30 |
| JP2004513171A5 true JP2004513171A5 (https=) | 2005-12-22 |
| JP4302980B2 JP4302980B2 (ja) | 2009-07-29 |
Family
ID=26245271
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002541100A Expired - Fee Related JP4302980B2 (ja) | 2000-11-10 | 2001-11-08 | Ｇａｂａ受容体リガンドとしてのイミダゾ−トリアジン誘導体 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6936608B2 (https=) |
| EP (1) | EP1343788B1 (https=) |
| JP (1) | JP4302980B2 (https=) |
| AT (1) | ATE310740T1 (https=) |
| AU (2) | AU1253002A (https=) |
| CA (1) | CA2427779A1 (https=) |
| DE (1) | DE60115282T2 (https=) |
| ES (1) | ES2251518T3 (https=) |
| WO (1) | WO2002038568A1 (https=) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0117277D0 (en) | 2001-07-16 | 2001-09-05 | Merck Sharp & Dohme | Therapeutic agents |
| GB0128499D0 (en) * | 2001-11-28 | 2002-01-23 | Merck Sharp & Dohme | Therapeutic agents |
| GB0210127D0 (en) * | 2002-05-02 | 2002-06-12 | Merck Sharp & Dohme | Therapeutic agents |
| GB0212048D0 (en) * | 2002-05-24 | 2002-07-03 | Merck Sharp & Dohme | Therapeutic agents |
| CA2495285A1 (en) * | 2002-08-13 | 2004-02-19 | Merck Sharp & Dohme Limited | Phenylpyridazine derivatives as ligands for gaba receptors |
| US7485640B2 (en) | 2002-11-06 | 2009-02-03 | Merck Sharp & Dohme Limited | Imidazopyrazinones as GABA-A receptor anxiolytics |
| JPWO2005019238A1 (ja) | 2003-08-22 | 2006-10-19 | 明治製菓株式会社 | 新規アザライド及びアザラクタム誘導体とその製造法 |
| EP2258358A3 (en) | 2005-08-26 | 2011-09-07 | Braincells, Inc. | Neurogenesis with acetylcholinesterase inhibitor |
| EP1928437A2 (en) | 2005-08-26 | 2008-06-11 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
| EP1940389A2 (en) | 2005-10-21 | 2008-07-09 | Braincells, Inc. | Modulation of neurogenesis by pde inhibition |
| US20070112017A1 (en) | 2005-10-31 | 2007-05-17 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
| US7465795B2 (en) | 2005-12-20 | 2008-12-16 | Astrazeneca Ab | Compounds and uses thereof |
| AU2006327300A1 (en) | 2005-12-20 | 2007-06-28 | Astrazeneca Ab | Substituted Cinnoline derivatives as GABAa-receptor modulators and method for their synthesis |
| US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
| AU2007249399A1 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
| WO2007134077A2 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | 5 ht receptor mediated neurogenesis |
| EP2068872A1 (en) | 2006-09-08 | 2009-06-17 | Braincells, Inc. | Combinations containing a 4-acylaminopyridine derivative |
| ME02372B (me) | 2006-11-22 | 2016-06-20 | Incyte Holdings Corp | Imidazotriazini i imidazopiramidini kao inhibitori kinaze |
| WO2010099217A1 (en) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
| US20110082147A1 (en) * | 2009-07-24 | 2011-04-07 | Concert Pharmaceuticals, Inc. | Substituted imidazotriazines |
| CN102030770B (zh) * | 2009-09-25 | 2012-10-31 | 北京大学 | 一种芳香硼酸酯化合物的制备方法 |
| EP2468726B1 (en) * | 2010-12-06 | 2013-08-28 | Siena Biotech S.p.A. | Compound for the treatment of tumours and tumour metastases |
| CN102898315B (zh) * | 2012-11-05 | 2015-01-28 | 上海毕得医药科技有限公司 | 3-乙炔基-4-氟苯胺的制备方法 |
| UA112028C2 (uk) | 2012-12-14 | 2016-07-11 | Пфайзер Лімітед | Похідні імідазопіридазину як модулятори гамка-рецептора |
| CN104177304A (zh) * | 2013-05-28 | 2014-12-03 | 海洋王照明科技股份有限公司 | 双极性蓝光磷光主体材料及其制备方法和有机电致发光器件 |
| GB201321732D0 (en) * | 2013-12-09 | 2014-01-22 | Ucb Pharma Sa | Therapeutic agents |
| SI3105218T1 (sl) | 2014-02-13 | 2019-11-29 | Incyte Corp | Ciklopropilamini kot inhibitorji LSD1 |
| US9527835B2 (en) | 2014-02-13 | 2016-12-27 | Incyte Corporation | Cyclopropylamines as LSD1 inhibitors |
| MX373103B (es) | 2014-02-13 | 2020-04-17 | Incyte Holdings Corp | Ciclopropilaminas como inhibidores de desmetilasa específica de lisina 1 (lsd1). |
| EP3154979B1 (en) | 2014-06-12 | 2018-03-07 | Pfizer Limited | Imidazopyridazine derivatives as modulators of the gabaa receptor activity. |
| WO2016007722A1 (en) | 2014-07-10 | 2016-01-14 | Incyte Corporation | Triazolopyridines and triazolopyrazines as lsd1 inhibitors |
| TWI687419B (zh) | 2014-07-10 | 2020-03-11 | 美商英塞特公司 | 作為ｌｓｄ１抑制劑之咪唑并吡啶及咪唑并吡嗪 |
| TW201613925A (en) | 2014-07-10 | 2016-04-16 | Incyte Corp | Imidazopyrazines as LSD1 inhibitors |
| EP3277689B1 (en) | 2015-04-03 | 2019-09-04 | Incyte Corporation | Heterocyclic compounds as lsd1 inhibitors |
| LT3334709T (lt) | 2015-08-12 | 2025-03-10 | Incyte Holdings Corporation | Lsd1 inhibitoriaus druskos |
| SG11201806393QA (en) | 2016-01-27 | 2018-08-30 | Univ Zuerich | Use of gabaa receptor modulators for treatment of itch |
| WO2018175659A1 (en) | 2017-03-21 | 2018-09-27 | Mississippi State University | Unsymmetrical salts, ccc-nhc pincer metal complexes, and methods of making the same |
| JP7449272B2 (ja) * | 2018-04-18 | 2024-03-13 | ニューロサイクル・セラピューティクス・インコーポレイテッド | Ｇａｂａａ陽性アロステリックモジュレーター化合物、その作製の方法および使用 |
| WO2020047198A1 (en) | 2018-08-31 | 2020-03-05 | Incyte Corporation | Salts of an lsd1 inhibitor and processes for preparing the same |
| JP2022553718A (ja) * | 2019-10-22 | 2022-12-26 | ニューロサイクル・セラピューティクス・インコーポレイテッド | Ｇａｂａａ陽性アロステリック調節因子化合物、作成方法、およびその使用 |
| KR20220087507A (ko) * | 2019-10-23 | 2022-06-24 | 뉴로사이클 테라퓨틱스, 인크. | Gabaa 수용체 조절제를 사용한 간질 병태의 치료 |
| KR102537615B1 (ko) * | 2020-02-25 | 2023-05-30 | 주식회사 종근당 | 히스톤 탈아세틸화효소 6 억제제로서의 1,3,4-옥사다이아졸 유도체 화합물 및 이를 포함하는 약제학적 조성물 |
| CN116693555B (zh) * | 2022-02-25 | 2025-07-04 | 上海赛默罗生物科技有限公司 | 咪唑并哒嗪类衍生物、其制备方法、药物组合物和用途 |
| CN117069725A (zh) | 2022-05-10 | 2023-11-17 | 上海赛默罗生物科技有限公司 | 咪唑并哒嗪取代苯环类衍生物、制备方法、药物组合物及用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1581125B1 (de) * | 1966-03-26 | 1970-08-27 | Maierform Trust Reg | Bug fuer Verdraengungsschiffe |
| US3422194A (en) * | 1967-08-15 | 1969-01-14 | Smithkline Corp | The treatment of depression with imidazo(1,2-b)-as-triazines and compositions thereof |
| CN1167686C (zh) * | 1999-06-22 | 2004-09-22 | 神经研究公司 | 苯并咪唑衍生物和包括这些化合物的药物组合物 |
| GB0117277D0 (en) * | 2001-07-16 | 2001-09-05 | Merck Sharp & Dohme | Therapeutic agents |
-
2001
- 2001-11-08 CA CA002427779A patent/CA2427779A1/en not_active Abandoned
- 2001-11-08 WO PCT/GB2001/004948 patent/WO2002038568A1/en not_active Ceased
- 2001-11-08 US US10/416,318 patent/US6936608B2/en not_active Expired - Fee Related
- 2001-11-08 ES ES01980742T patent/ES2251518T3/es not_active Expired - Lifetime
- 2001-11-08 JP JP2002541100A patent/JP4302980B2/ja not_active Expired - Fee Related
- 2001-11-08 EP EP01980742A patent/EP1343788B1/en not_active Expired - Lifetime
- 2001-11-08 AT AT01980742T patent/ATE310740T1/de not_active IP Right Cessation
- 2001-11-08 AU AU1253002A patent/AU1253002A/xx active Pending
- 2001-11-08 AU AU2002212530A patent/AU2002212530B2/en not_active Ceased
- 2001-11-08 DE DE60115282T patent/DE60115282T2/de not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004513171A5 (https=) | ||
| CA2461426A1 (en) | Imidazo-pyrimidine derivatives as ligands for gaba receptors | |
| ES2611588T3 (es) | Pirrolo[2,3-b]piridinas y pirrolo[2,3-b]pirimidinas sustituidas con heteroarilo como inhibidores de quinasas Janus | |
| HRP20171454T1 (hr) | Fuzionirani heterociklični spojevi kao modulatori ionskih kanala | |
| RU2019118623A (ru) | Пирролопиримидины в качестве потенциаторов мвтр | |
| JP2007523182A5 (https=) | ||
| JP2009536196A5 (https=) | ||
| RU2010143541A (ru) | Бициклические нитроимидазолы, ковалентно соединенные с замещенными фенилоксазолидинонами | |
| JP2006504658A5 (https=) | ||
| JP2011501735A5 (https=) | ||
| JP2020527560A5 (https=) | ||
| CA2557856A1 (en) | 3-'4-heterocyclyl-1,2,3,-triazol-1-yl!-n-aryl-benzamides as inhibitors of the cytokines production for the treatment of chronic inflammatory diseases | |
| JP2004523585A5 (https=) | ||
| JP2014513134A5 (https=) | ||
| JP2017535561A5 (https=) | ||
| JP2004525149A5 (https=) | ||
| JP2018524331A5 (https=) | ||
| JP2013518046A5 (https=) | ||
| JP2012502010A5 (https=) | ||
| EA011691B1 (ru) | ИМИДАЗО(1,2-a)ПИРИДИНОВЫЕ СОЕДИНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ VEGF-R2 | |
| JP2013508403A5 (https=) | ||
| RU2017112518A (ru) | Пиридоновые и азапиридоновые соединения и способы применения | |
| JP2009525340A5 (https=) | ||
| JP2008523041A5 (https=) | ||
| JP2009536197A5 (https=) |